| CAS: | 322-79-2 | |||||||||
| 分子式: | C10H7F3O4 | |||||||||
| 分子量: | 248.16 | |||||||||
| 熔点: | 113-117°C | |||||||||
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 | ||||||||||||||||||||||||||||||||||||||||||||||||
| T794293 | MACKLIN | 三氟醋柳酸 | 10mM in DMSO | 581元/1ml; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||
储存：-20°C | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| T868602 | MACKLIN | 三氟醋柳酸 | ≥98% | 859元/250mg; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||
储存：2-8°C | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| T3601 | TCI | Triflusal | >98.0%(T) | 990元/250MG; 2650元/1G; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
技术规格
物性(参考值)
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| T2005000 | Triflusal | European Pharmacopoeia (EP) Reference Standard | 1861.35元/ ; | 展开 | |||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 Triflusal is an anti-inflammatory antithrombotic platelet aggregation inhibitor with a 3-fold mechanism of action. It is an irreversible inhibitor of COX-1 inhibiting thromboxane A2, preventing aggregation; it preserves vascular prostacyclin, thus promoting anti-aggregant effect. Triflusal blocks phosphodiesterase leading to an increase in cAMP levels promoting anti-aggregant effect due to inhibition of calcium mobilization. 包装 Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| T6580 | Sigma-Aldrich | Triflusal | ≥98% (HPLC), powder | 1225.94元/5 MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 包装 5, 25 mg in glass bottle 生化/生理作用 Triflusal is an anti-inflammatory antithrombotic platelet aggregation inhibitor with a 3-fold mechanism of action. It is an irreversible inhibitor of COX-1 inhibiting thromboxane A2, preventing aggregation; it preserves vascular prostacyclin, thus promoting anti-aggregant effect. Triflusal blocks phosphodiesterase leading to an increase in cAMP levels promoting anti-aggregant effect due to inhibition of calcium mobilization. 特点和优势 This compound was developed by Uriach. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
m.cnreagent.com
